Maria Feychting: Microwave News Article Archive (2004 - )

Two influential health agencies, both based in France, will host a one-day meeting on RF–health research, November 23 in Paris. The public is invited to attend in person or online. Registration is free.

The conference, organized by ANSES, the French Agency for Food, Environmental and Occupational Health & Safety, and IARC, the International Agency for Research on Cancer, will focus on potential effects of RF radiation on the brain and on cancer risks. The theme is “Research in a Fast-Moving Environment.”

UPDATE: With no public notice or any formal announcement, the World Health Organization (WHO) held the first meeting of its RF Working Group in Geneva March 14-16, 2023.

The group is preparing a review of health effects, as part of a process that has been ongoing for close to a decade.

Our latest chapter, “RF Review Shrouded in Secrecy,” is posted here.

___________

After eight years of work, the WHO is reopening its review of the health effects of RF radiation for a summary report intended to serve as a benchmark for its more than 150 member countries. The report will be used as a guide to respond to widespread concerns over the new world of 5G.

The WHO issued a public call in October for detailed literature reviews on ten types of RF–health impacts from cancer to fertility to electrohypersensitivity. Some see the move as a sign that the health agency is interested in opinions beyond those of its long-time partner, the International Commission on Non-Ionizing Radiation Protection (ICNIRP). They hope that the WHO is finally ready to recognize evidence of low-level effects, in particular the link between cell phones and cancer. Others are far from convinced.

The skeptics see the new reviews as little more than a ruse.

It has been nearly eight years since an expert panel of the International Agency for Research on Cancer (IARC) classified RF radiation as a possible human carcinogen. Since then, neither the World Health Organization (WHO) nor the International Commission on Non-Ionizing Radiation Protection (ICNIRP) has recommended precautionary policies to limit potential health risks.

No U.S. health agency has yet advised the public to reduce RF exposures.

Even after two large animal studies —by the U.S. National Toxicology Program (NTP) and Italy’s Ramazzini Institute— presented clear evidence of a cancer link last year, the WHO has remained silent; ICNIRP responded by calling both animal studies unconvincing.

Now comes the Annual Review of Public Health, which on January 11 posted a paper by five leading epidemiologists who posit that, after a systematic review of all the human studies, they don’t see an elevated cancer risk. The takeaway is that the IARC classification was a mistake.

Why was the NTP so ambivalent about its cell phone cancer findings at the press conference last Friday when two years ago the same scientific evidence prompted a public health warning?

Some of the pathology numbers got tweaked since they were first released in 2016, but the changes were minor. It’s the same data set —but with a very different interpretation. The NTP mindset somehow shifted from we need to release this important new health data now to this is “not a high-risk situation.”

Who or what moved the NTP managers to change their outlook? There’s no shortage of suspects and suspicions.

INTEROCC and INTERPHONE have a lot in common —more than their first five letters. So much in common that it’s a bit freaky. Or, maybe it just shows, once again, how small, insulated and polarized the EMF community is.

The most obvious parallels are that Elisabeth Cardis is the principal investigator of both the...

The Supreme Court of Italy has affirmed a ruling granting worker's compensation to a businessman who developed a tumor after using a cell phone for 12 years. This is the first time that a high court —in any country— has ruled in favor a link between mobile phone radiation and tumor development.

Innocente Marcolini, a financial manager at an industrial plant in Brescia in northern Italy, used cell and cordless phones for five-to-six hours a day for 12 years. Then, one morning ten years ago, Marcolini sensed an unusual tingling in his chin while shaving. He was soon diagnosed as having a benign tumor on the trigeminal nerve, which controls facial muscles and sensations.

Marcolini filed for workers' compensation alleging that his wireless phones were responsible for the tumor. At first, his claim was rejected. But, in December 2009, the Court of Appeals in Brescia reversed that decision and, on October 12, Italy's Supreme Court affirmed the Appeals Court's ruling. No further appeals are possible.

The latest update of the Danish cell phone-cancer study is being touted as the biggest and best ever. It shows “no link between mobile phone use and [brain] tumors,” according to the press release.

Don’t believe a word of it.

On October 20, the British Medical Journal released the third installment of the Danish Cancer Society’s cohort study, which has been tracking some 400,000 mobile phones subscribers since the 1980s. The whole enterprise has been dogged by controversy and political suspicions since the first results were published ten years ago.

It's not easy to reach unanimous agreement on anything to do with cell phone radiation. And when it comes to cell phones and cancer, forget about it. But the International Agency for Research on Cancer (IARC) nearly pulled it off. On Tuesday, May 31, more than two dozen scientists and doctors from 14 countries —a group IARC Director Christopher Wild called “the world’s leading experts”— issued a joint statement that cell phone and other types of radiofrequency (RF) and microwave radiation might cause cancer.

The International Agency for Research on Cancer (IARC) has recruited Joachim Schüz to lead its Section on Environment. Among his duties in Lyon, Schüz will supervise the still-unfinished work of theInterphone project. He will also play an advisory role in next year’s IARC review of the possible cancer risks associated with RF radiation. Schüz, who begins at the agency on August 2, will report to Christopher Wild, the director of IARC.